Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | Services |
| Procurement Method: | Direct award |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 5 December 2025 |
| Application Deadline: | — |
| Contract Start Date: | — |
| Contract End Date: |
All 4 notices for this procurement, oldest first.
Blood Group Genotyping for Sickle Cell and Thalassaemia
Blood Group Genotyping for Sickle Cell and Thalassaemia
Blood Group Genotyping for Sickle Cell and Thalassaemia
Blood Group Genotyping for Sickle Cell and Thalassaemia
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award value: | £140,671 |
| Award decision date: | — |
| Award status: | Pending |
Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| — |
| Contract Duration: | NaN years |
| Procurement ID (OCID): | ocds-h6vhtk-05f01d |
| Notice Reference: | 080350-2025 |